מעכב סלקטיבי של egfr עם מוטצית החדרת exon 20
- 专利权人:
- TAIHO PHARMACEUTICAL CO. LTD.
- 发明人:
- 申请号：
- IL26623919
- 公开号：
- IL266239D0
- 申请日:
- 2019.04.24
- 申请国别(地区):
- IL
- 年份:
- 2019
- 代理人:
- 摘要：
- An antitumor agent comprising a compound selected from the group consisting of Compounds A to D described in the specification, or a salt thereof, for treating a malignant tumor patient expressing EGFR having exon 20 insertion mutation.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SELECTIVE INHIBITOR OF EXON 20 INSERTION MUTANT EGFR
- Exxon 20-Insertion Mutant EGFR Selective Inhibitor
- IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
- Use the combined antitumor agent with kinase inhibitory activity
- AGENTE IMUNOSSUPRESSOR COMPREENDENDO UM COMPOSTO HETEROCÍCLICO COMO INGREDIENTE ACTIVO
